Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen SV, Denmark.
Am J Physiol Cell Physiol. 2022 Apr 1;322(4):C769-C774. doi: 10.1152/ajpcell.00059.2022. Epub 2022 Mar 2.
The breakthrough technology for reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has created a new path for science and medicine. The iPSC technology provides a powerful tool for elucidating the mechanisms of cellular differentiation and cell fate decision as well as to study targets and pathways relevant to pathological processes. As they can be generated from any person, iPSCs are a promising resource for regenerative medicine potentiating the possibility to discover new drugs in a high-throughput screening format and treat diseases through personalized cell therapy-based strategies. However, the reprogramming process is complex, and its regulation needs fine tuning. The regulatory mechanisms of cell reprogramming and differentiation are still not elucidated, but significant results show that multiple long noncoding RNAs (lncRNAs) play essential roles. In this mini-review, we discuss the latest research on lncRNAs in iPSC stemness, neuronal, and cardiac differentiation.
重编程体细胞为诱导多能干细胞 (iPSC) 的突破性技术为科学和医学开辟了新的途径。iPSC 技术为阐明细胞分化和细胞命运决定的机制以及研究与病理过程相关的靶点和途径提供了强大的工具。由于它们可以从任何人身上产生,iPSC 是再生医学的有前途的资源,有可能通过高通量筛选的方式发现新药,并通过基于个性化细胞治疗的策略来治疗疾病。然而,重编程过程很复杂,其调控需要精细调整。细胞重编程和分化的调控机制尚不清楚,但大量研究结果表明,多个长非编码 RNA (lncRNA) 发挥着重要作用。在这篇迷你综述中,我们讨论了 lncRNA 在 iPSC 干性、神经元和心脏分化中的最新研究进展。